¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cellular sensitivity"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cellular sensitivity
    ¼¼Æ÷¹Î°¨µµ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cross sensitivity
    ±³Â÷¹Î°¨µµ
  • denervation sensitivity
    Å»½Å°æ¹Î°¨µµ
  • diagnostic sensitivity
    Áø´Ü¹Î°¨µµ
  • disc sensitivity test
    ¿ø¹Ý¹Î°¨°Ë»ç
  • insulin sensitivity index
    Àν¶¸°¹Î°¨Áö¼ö
  • international sensitivity index
    ±¹Á¦¹Î°¨µµÁö¼ö
  • optimal sensitivity
    ÃÖÀû¹Î°¨µµ
  • physics depth sensitivity
    ¹°¸®Àû±íÀ̹ਵµ
  • primaquine sensitivity
    ÇÁ¸®¸¶Äý¹Î°¨µµ
  • spectral sensitivity
    ºÐ±¤¹Î°¨µµ
  • sensitivity
    1. °¨¼ö¼º 2. ¹Î°¨µµ
  • sensitivity control
    °¨µµÁ¶Á¤±â, °¨µµÁ¶Àý
  • sensitivity current
    °¨µµÀü·ù
  • sensitivity test
    ¹Î°¨µµ°Ë»ç
  • short increment sensitivity index test
    ¹Ì¼¼Áõ°¡°¨¼ö¼ºÁö¼ö°Ë»ç
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sensitivity
    1.°¨¼ö¼º, °¨°¢, 2.¹Î°¨µµ
  • cellular type
    ¼¼Æ÷Çü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cellular sensitivity
    ¼¼Æ÷¹Î°¨µµ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sensitivity control
    °¨µµÁ¶Á¤±â, °¨µµÁ¶Àý
  • sensitivity current
    °¨µµÀü·ù
  • denervation sensitivity
    Å»½Å°æ°ú¹Î, Å»½Å°æ¹Î°¨µµ
  • diagnostic sensitivity
    Áø´Ü¹Î°¨µµ
  • disc sensitivity test
    ¿øÆÇ¹Î°¨°Ë»ç
  • leucine sensitivity hypoglycemia
    ·ù½Å¹Î°¨ÀúÇ÷´çÁõ
  • insulin sensitivity index
    Àν¶¸°°¨¼ºÁö¼ö
  • international sensitivity index
    ±¹Á¦¹Î°¨µµÁö¼ö
  • optimal sensitivity
    ÃÖÀû¹Î°¨µµ
  • oxytocin sensitivity test
    ¿Á½ÃÅä½Å¹Î°¨µµ°Ë»ç
  • physics depth sensitivity
    ¹°¸®Àû±íÀ̹ਵµ
  • primaquine sensitivity
    ÇÁ¸®¸¶Äý¹Î°¨µµ
  • radiation sensitivity test
    ¹æ»ç¼±¹Î°¨µµ°Ë»ç
  • sensitivity
    ¹Î°¨µµ
  • sensitivity test
    ¹Î°¨µµ½ÃÇè
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • high cellular component
    °í¼¼Æ÷ ±¸¼º ¼ººÐ
  • hypersensitivity, cellular
    ¼¼Æ÷¼º °ú¹Î¹ÝÀÀ
  • impaired cellular immunity
    ¼¼Æ÷¼º ¸é¿ªºÎÀü(á¬øààõØóæ¹ÝÕîï).
  • ISI => International Sensitivity Index
    ±¹Á¦¿¹¹ÎµµÁö¼ö
  • International Sensitivity Index
    ±¹Á¦¿¹¹ÎµµÁö¼ö
  • International Sensitivity Index=ISI
    ±¹Á¦¹Î°¨µµÁö¼ö
  • TB sensitivity plate
    °áÇÙ±Õ°¨¼ö¼ºÆòÆÇ
  • in vitro sensitivity testing
    ½ÃÇè°ü³» °¨¼ö¼º ½ÃÇè
  • insulin sensitivity
    Àν¶¸°°¨(¼ö)¼º.
  • insulin sensitivity index
    Àν¶¸°°¨¼ºÁö¼ö.
  • insulin sensitivity test
    Àν¶¸°°¨¼º½ÃÇè.
  • primaquine sensitivity
    ÇÁ¸®¸¶Äý°ú¹ÎÁõ.
  • radiation sensitivity
    ¹æ»ç¼±°¨¼ö¼º
  • radiation sensitivity test, RST
    ¹æ»ç¼±°¨¼ö¼º°Ë»ç
  • receptor sensitivity
    ¼ö¿ëü °¨¼ö¼º
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cellular sensitivity
    ¼¼Æ÷°¨¼ö¼º
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • contrast sensitivity
    ´ëºñ°¨µµ
  • contrast sensitivity chart
    ´ëºñ°¨µµÇ¥
  • corneal sensitivity
    °¢¸·Áö°¢
  • diagnostic sensitivity
    Áø´ÜÀû ¹Î°¨µµ
  • disc sensitivity test
    ¿øÆÇ°¨¼ö¼º°Ë»ç
  • electrode sensitivity
    Àü±Ø°¨¼ö¼º
  • in vitro sensitivity testing
    ½ÃÇè°ü³» °¨¼ö¼º ½ÃÇè
  • insulin sensitivity
    Àν¶¸°°¨(¼ö)¼º.
  • insulin sensitivity index
    Àν¶¸°°¨¼ºÁö¼ö.
  • insulin sensitivity test
    Àν¶¸°°¨¼º½ÃÇè.
  • leucine sensitivity hypoglycemia
    ·ù½Å°¨¼ö¼º ÀúÇ÷´çÁõ.
  • optimal sensitivity
    ÃÖÀû°¨µµ(õÌîêÊïöô).
  • optimum sensitivity
    ÃÖÀû°¨µµ(õÌîêÊïöô).
  • optochin disc sensitivity test
    ¿ÉÅäŲ ¿øÆÇ°¨¼ö¼º½ÃÇè (Æó·Å±¸±Õ µ¿Á¤¿ë)
  • optochin sensitivity
    ¿ÉÅäŲ °¨¼ö¼º°Ë»ç (Æó·Å±¸±Õ µ¿Á¤¿ë)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Cellular deficiency (Acallosal cerebrum)
    ¼¼Æ÷°áÇÌ (³úµéº¸°á¿©³ú)
    [¿¾ ¿ë¾î] ¼¼Æ÷°áÇÌ
  • Cellular granule
    ¼¼Æ÷°ú¸³
    [¿¾ ¿ë¾î] ¼¼Æ÷°ú¸³
  • Cellular process
    ¼¼Æ÷µ¹±â
    [¿¾ ¿ë¾î] ¼¼Æ÷µ¹±â
  • Cellular islands
    ¼¼Æ÷¼¶
    [¿¾ ¿ë¾î] ¼¼Æ÷µµ
  • Cellular connective tissue
    ¼¼Æ÷¼º°áÇÕÁ¶Á÷
    [¿¾ ¿ë¾î] ¼¼Æ÷¼º°áÇÕÁ¶Á÷
  • Cellular membrane
    ¼¼Æ÷¼º¸·
    [¿¾ ¿ë¾î] ¼¼Æ÷¼º¸·
  • Cellular cementum
    ¼¼Æ÷½Ã¸àÆ®Áú
    [¿¾ ¿ë¾î] ¼¼Æ÷¼º½Ã¸àÆ®Áú
  • Cellular layer
    ¼¼Æ÷ÆÇ
    [¿¾ ¿ë¾î] ¼¼Æ÷Ãþ
  • Cellular invagination
    ¼¼Æ÷ÇÔÀÔ
    [¿¾ ¿ë¾î] ¼¼Æ÷ÇÔÀÔ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • oligomycin-sensitivity-conferring factor
    ¿Ã¸®°í¸¶À̽а¨¼ö¼ººÎ¿©ÀÎÀÚ(Êïáôàõݾæ¨ì×í­)
  • primaquine sensitivity
    ÇÁ¸®¸¶Äý °¨¼ö¼º(Êïáôàõ)
  • sensitivity
    "(¹Î)°¨µµ((ÚÂ)ÊïÓø), °¨¼ö¼º(Êïáôàõ)"
  • antibody dependent cellular cytotoxicity
    Ç×üÀÇÁ¸ÀÚ¸® ¼¼Æ÷¼º¼¼Æ÷µ¶¼º(ù÷ô÷ëîðíá¬øààõá¬øàÔ¸àõ)
  • cellular immunity
    ¼¼Æ÷¸é¿ª(á¬øàØóæ¹)
  • cellular oncogene
    ¼¼Æ÷ ¾ÏÀ¯ÀüÀÚ(á¬øàäßë¶îîí­)
  • cellular respiration
    ¼¼Æ÷È£Èí(á¬øàû¼ýå)
  • cellular retinol-binding protein
    ¼¼Æ÷(á¬øà) ·¹Æ¼³î°áÇÕ(Ì¿ùê) ´Ü¹éÁú(Ó±ÛÜòõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • high cellular component
    °í¼¼Æ÷±¸¼º¼ººÐ
  • physics depth sensitivity
    ¹°¸®Àû±íÀÌ¿¹¹Îµµ
  • radiation sensitivity
    ¹æ»ç¼±°¨¼ö¼º
  • section sensitivity profile(SSP)
    ÀýÆí¹Î°¨Ãø¸é
  • sensitivity
    °¨µµ, °¨¼ö¼º, °¨ÀÀ¼º, ¹Î°¨¼º(µµ)
  • sensitivity of speed
    °¨µµ
  • sensitivity tests
    °¨µµ½ÃÇè, °¨¼ö(¼º)½ÃÇè
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CS calf serum; campomelic syndrome; carcinoid syndrome; cardiogenic shock; caries-susceptible; carotid ...
ISI infarct size index; initial slope index; injury severity index; Institute for Scientific Information...
MCS malignant carcinoid syndrome; managed care system; massage of the carotid sinus; mesocaval shunt; me...
ADCC cell Antibody Dependent Cellular(= Cell-Mediated) Cytotoxicity cell
ECF   1) Eosinophilic Chemotatic Factors
  2) Extra-Cellular Fluid; ¼¼Æ÷ ¿Ü¾×
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
APC SR APC sensitivity ratio
ASI Anxiety Sensitivity Index
AS Anxiety sensitivity
BRS Baroreceptor reflex sensitivity
BRS Baroreflex sensitivity
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cellular sensitivity
    ¼¼Æ÷ °¨¼ö¼º
    ¼¼Æ÷°¡ °¨¼ö¼ºÀÌ ÀÖ´Â »óÅ ¶Ç´Â ¼ºÁú·Î¼­, Àڱؿ¡ ´ëÇØ¼­ ºñÁ¤»óÀûÀ¸·Î ¹ÝÀÀÇϰųª ¶Ç´Â ºü¸£°í ¿¹¹ÎÇÏ°Ô ¹ÝÀÀÇÏ´Â »óŸ¦ ³ªÅ¸³»´Â µ¥ Á¾Á¾ »ç¿ëµÈ´Ù.
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cross sensitivity
    ±³Â÷ °ú¹Î ¹ÝÀÀ
  • dentin sensitivity
    »ó¾ÆÁú °¨¼ö¼º
    Ä¡°ú Áø·á ½Ã »ó¾ÆÁúÀ» ħ¹üÇÒ °æ¿ì ȯÀÚ°¡ µ¿ÅëÀ» ´À³¢´Â Á¤µµ.
  • dietary sensitivity
    À½½Ä¹°¿¡ ´ëÇÑ °ú¹Î¼º
  • disc sensitivity test
    ¿øÆÇ °¨¼ö¼º °Ë»ç
  • local muscle sensitivity
    ±¹¼ÒÀû ±Ù°ú¹Î¼º
  • mechanical sensitivity
    ±â°èÀû °¨µµ
  • optimum sensitivity
    ÃÖÀû °¨µµ
  • oxytocin sensitivity test
    ¿Á½ÃÅä½Å °¨¼ö¼º °Ë»ç
  • pain sensitivity
    µ¿Åë ¹Î°¨µµ
    µ¿Åë ¼ö¿ë±â´Â Ã˰¨À̳ª ¾Ð¹Ú°¨¿¡ ´ëÇØ¼­´Â ¹ÝÀÀÇÏÁö ¾ÊÁö¸¸ Á¶Á÷À» ¼Õ»ó½Ãų Á¤µµÀÇ Ã˰¢¿¡ ´ëÇØ¼­´Â ¹ÝÀÀÇÑ´Ù. µ¿Åë Àü´Þ°è´Â °¡²û µ¿Åë¿¡ °ú¹ÎÇÏ°Ô ¹ÝÀÀÇϴµ¥ À̸¦ µ¿Åë °ú¹ÎÁõÀ̶ó ÇÑ´Ù.
  • radiation sensitivity
    ¹æ»ç¼± °¨¼ö¼º
  • sensitivity
    °¨µµ, °¨¼ö¼º, °¨ÀÀ¼º, ¹Î°¨¼º, ¹Î°¨¼ºµµ, °ú¹Î¼º
    °¨¼ö¼ºÀÌ ÀÖ´Â »óÅ ¶Ç´Â ¼ºÁú·Î¼­, Àڱؿ¡ ´ëÇØ¼­ ºñÁ¤»óÀûÀ¸·Î ¹ÝÀÀÇϰųª ¶Ç´Â ºü¸£°í ¿¹¹ÎÇÏ°Ô ¹ÝÀÀÇÏ´Â »óŸ¦ ³ªÅ¸³»´Â µ¥ Á¾Á¾ »ç¿ëµÈ´Ù.
  • sensitivity disk method
    °¨¼ö¼º µð½ºÅ©¹ý
  • sensitivity range
    ¹Î°¨µµ ¹üÀ§
  • sensitivity test
    °¨µµ °Ë»ç, °¨µµ ½ÃÇè, °¨¼ö ½ÃÇè, °¨¼ö¼º ½ÃÇè, °¨¼ö¼º °Ë»ç
    ±ÕÀÇ È­ÇÐ ¿ä¹ýÁ¦¿¡ ´ëÇÑ °¨¼ö¼ºÀ» Á¶»çÇÏ¿© ±× °á°ú¿¡ À¯È¿ÇÑ ¾àÁ¦¸¦ ¼±ÅÃÇϱâ À§ÇØ ½Ç½ÃÇÏ´Â °Ë»ç.
  • sensitivity to touch of the scalp
    µÎÇÇ Á¢ÃË ½ÃÀÇ °ú¹Î¼º
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
acute cellular rejection Graft rejection which usually begins within 10 days after a graft has been transplanted into a genetically dissimilar host. Lesions at the site of the graft characteristically are infiltrated with large numbers of lymphocytes and macrophages which cause tissue damage.
See: primary rejection.
Synonym: acute rejection.
(05 Mar 2000)
cellular 1. Relating to, derived from, or composed of cells.
2. Having numerous compartments or interstices.
Origin: L. Cellula, dim. Of cella, storeroom
(05 Mar 2000)
cellular biology <study> The study of cells. Implies the use of light or electron microscopic methods for the study of morphology.
(18 Nov 1997)
cellular biophysics Biophysics concerned with cellular processes.
(05 Mar 2000)
cellular blue nevus A large, acquired blue nevus in which melanocytes are often clear and large, alternating with pigmented spindle cells and which may expand deeply into the subcutis; malignant change is very rare.
(05 Mar 2000)
cellular cartilage An embryonic or immature stage of cartilage in which it consists chiefly of cells with very little matrix.
Synonym: parenchymatous cartilage.
(05 Mar 2000)
cellular embolism Embolism due to a mass of cells transported from disintegrating tissue.
(05 Mar 2000)
cellular engineering <technique> The use of techniques for constructing replacement or additional or experimental parts of cells and tissues for both fundamental investigation and as prosthetic devices. Often involves the interfacing of cells and nonliving structures.
(26 Mar 1998)
cellular immune theory A concept, put forth by Elie Metchnikoff, that cells, not antibodies, were responsible for the immune response of an organism.
(05 Mar 2000)
cellular immunity <cell biology, immunology> Immune response that involves enhanced activity by phagocytic cells and does not imply lymphocyte involvement. Since the term is easily confused with cell-mediated immunity its use in this sense should be avoided.
(26 Mar 1998)
cellular immunity deficiency syndrome <syndrome> A syndrome marked by increased susceptibility to infection, especially to viral infection, associated with defective functioning of the mechanism responsible for acquired immunity of the cell-mediated kind.
See: immunodeficiency.
(05 Mar 2000)
cellular immunodeficiency with abnormal immunoglobulin synthesis An ill-defined group of sporadic disorders of unknown cause, occurring in both males and females and associated with recurrent bacterial, fungal, protozoal, and viral infections; there is thymic hypoplasia with depressed cellular (T-lymphocyte) immunity combined with defective humoral (B-lymphocyte) immunity, although immunoglobulin levels may be normal.
Synonym: Nezelof syndrome, Nezelof type of thymic alymphoplasia.
(05 Mar 2000)
cellular infiltration Migration of cells from their sources of origin, or direct extension of cells as a result of unusual growth and multiplication, thereby resulting in fairly well-defined foci, irregular accumulations, or diffusely distributed individual cells in the connective tissue and interstices of various organs and tissues; used especially with reference to such changes associated with inflammations and certain types of malignant neoplasms.
(05 Mar 2000)
cellular microbiology <study> A new discipline emerging at the interface between cell biology and microbiology. One major focus of this new field is on the interference of pathogenic bacteria with many eukaryotic cell functions, such as maturation of intracellular compartments, internal cellular communication, or even cell division and differentiation.
The study of cellular mcirobiology in this respect, is providing a sophisticaled tool kit for mammalian cell biologists.
(26 Mar 1998)
cellular mosaicism A chimerism in which a tissue contains cells from different zygotes; e.g., in humans, involving erythrocytes.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sensitivity
    ¹Î°¨µµ
  • sensitivity
    ¹Î°¨(¼º);°¨(¼ö)¼º;°¨±¤µµ
  • cellular
    ¼¼Æ÷ÀÇ
  • cellular
    ¼¼Æ÷ÀÇ,¼¼Æ÷Áú(¸ð¾ç)ÀÇ;¼º±â°Ô § (¼ÅÃ÷µî);´Ù°øÁúÀÇ;ÅëÈ­Á¸(zone)½ÄÀÇ;¼¿ ¹æ½ÄÀÇ(À°»ó À̵¿ Åë½ÅÀÇ »õ·Î¿î ¹æ½Ä)
  • cellular engineering
    ¼¼Æ÷ °øÇÐ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á